Phase Forward to Participate in Upcoming Investor Conferences
February 03 2010 - 8:30AM
Business Wire
Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of
data management solutions for clinical trials and drug safety,
today announced its participation in two upcoming investor
conferences in February.
Chairman and chief executive officer, Bob Weiler, and senior
vice president and chief financial officer, Chris Menard, will
participate in:
- The UBS 20th Annual Global
Healthcare Services Conference in New York City. The presentation
is scheduled for Monday, February 8, 2010 at 2:00 p.m. ET.
- The Thomas Weisel Partners
Technology and Telecom Conference 2010 in San Francisco. The
fireside chat is scheduled for Tuesday, February 9, 2010 at 2:05
p.m. PT.
The events will be webcast live and will be available by
visiting the Investors section of the company’s website at
www.phaseforward.com. The webcasts will be archived on the
company’s website for 30 days after the conference ends.
About Phase Forward
Phase Forward is a leading provider of integrated data
management solutions for clinical trials and drug safety. Phase
Forward's products and services have been utilized in over 10,000
clinical trials involving more than 1,000,000 clinical trial study
participants at over 300 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber
Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration,
GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono,
Novartis, Novo Nordisk, PAREXEL International, Procter &
Gamble, Quintiles, sanofi-aventis, Schering-Plough Research
Institute, Servier, SGS, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about
Phase Forward is available at www.phaseforward.com.
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Phase Forward (NASDAQ:PFWD)
Historical Stock Chart
From Jul 2023 to Jul 2024